Latest News

Roche drug is third to win biomarker-driven cancer approval from FDA

Red seal and imprint "FDA APPROVED" on white surface. FDA - Food and Drug Administration is a federal agency of the United States Department of Health and Human Services.

On Thursday, Roche’s Rozlytrek won simultaneous FDA labels for NTRK fusion-positive solid tumors and ROS1-positive non-small cell lung cancer.

Source link

Related posts

Researchers find opportunity to control salt-sensitive hypertension without exercising


TransEnterix Gets FDA Green Light for Senhance Ultrasonic Instruments for Its Robots


Measles outbreaks are back


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy